|
Real-time Estimate
Cboe BZX
11:56:10 10/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 21.40 USD | -0.81% |
|
-6.84% | +28.65% |
| 05/09 | Denali Therapeutics Insider Sold Shares Worth $261,929, According to a Recent SEC Filing | MT |
| 25/08 | B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating | MT |
| Market Cap | 3.45B 2.97B 2.79B 2.55B 4.76B 328B 4.78B 33.11B 12.8B 167B 12.95B 12.67B 530B | P/E 2026 * |
-9.33x | P/E 2027 * | -9.41x |
|---|---|---|---|---|---|
| Enterprise Value | 2.74B 2.36B 2.22B 2.02B 3.78B 261B 3.8B 26.31B 10.17B 133B 10.29B 10.06B 421B | EV / Sales 2026 * |
54.2x | EV / Sales 2027 * | 20.8x |
| Free-Float |
90.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DNLI | Delayed | |
CBOE
| DNLI | Real-time | |
|
Boerse Muenchen
| 4DN | Real-time | |
|
Tradegate
| 4DN | Real-time | |
|
Deutsche Boerse AG
| 4DN | Delayed | |
|
Börse Stuttgart
| 4DN | Delayed |
Last Transcript : Denali Therapeutics Inc.
| 1 day | -0.46% | ||
| 1 week | -6.84% | ||
| Current month | -10.61% | ||
| 1 month | -15.04% | ||
| 3 months | +3.06% | ||
| 6 months | -0.89% | ||
| Current year | +28.65% |
| 1 week | 21.09 |  | 22.48 |
| 1 month | 21.09 | | 25.7 |
| Current year | 15.34 | | 27.3 |
| 1 year | 12.58 | | 27.3 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 56.08 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 01/05/2022 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 01/08/2015 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | 58 | 06/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 01/03/2015 |
Jay Flatley
BRD | Director/Board Member | 73 | 01/04/2015 |
David Schenkein
BRD | Director/Board Member | 68 | 01/04/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/9/26 | Sell | Director | -11,439 | 0.0072% | ||
| 1/9/26 | Sell | Founder | -2,768 | 0.0017% | ||
| 12/8/26 | Don | Founder | -32,220 | 0.0203% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.81% | -6.84% | +45.08% | -11.24% | 3.45B | |
| -0.94% | -0.71% | +45.60% | +103.25% | 68.52B | |
| -0.58% | -5.74% | +31.14% | +74.90% | 62.88B | |
| -0.55% | -0.21% | -13.38% | +377.02% | 28.13B | |
| -2.74% | -6.31% | +26.33% | +11.24% | 25.56B | |
| -1.48% | -6.29% | -4.54% | -18.26% | 24.65B | |
| -2.16% | -5.10% | +17.86% | -19.56% | 19.81B | |
| -4.27% | +3.07% | +211.22% | +362.48% | 17.69B | |
| -1.37% | -4.51% | -5.21% | +507.43% | 14.66B | |
| -0.63% | -2.20% | +53.40% | +162.98% | 14.45B | |
| Average | -1.53% | -2.03% | +40.75% | +155.02% | 27.98B | |
| Weighted average by Cap. | -1.35% | -1.91% | +36.49% | +135.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.57M 43.52M 40.97M 37.33M 69.85M 4.81B 70.13M 486M 188M 2.45B 190M 186M 7.77B | 130M 111M 105M 95.62M 179M 12.32B 180M 1.24B 481M 6.28B 486M 476M 19.89B |
| Net income | -454M -390M -368M -335M -627M -43.17B -629M -4.36B -1.68B -21.99B -1.7B -1.67B -69.67B | -449M -387M -364M -332M -621M -42.77B -623M -4.32B -1.67B -21.79B -1.69B -1.65B -69.02B |
| Net Debt | -708M -610M -574M -523M -979M -67.41B -982M -6.8B -2.63B -34.34B -2.66B -2.6B -109B | -749M -644M -607M -553M -1.03B -71.24B -1.04B -7.19B -2.78B -36.29B -2.81B -2.75B -115B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | USD 21.29 | -1.30% | 23,786 |
| 09/09/26 | USD 21.57 | -2.31% | 2,091,526 |
| 08/09/26 | USD 22.08 | -0.90% | 1,653,769 |
| 04/09/26 | USD 22.28 | -2.28% | 799,633 |
| 03/09/26 | USD 22.80 | -0.22% | 1,727,981 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
